Study of Pembrolizumab Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme Patients
- Substances:Pembrolizumab
Poland- Participants:18–64 years · 65+ years
- Substances:Pembrolizumab
- Sponsor:Agencja Badań Medycznych
Rare diseases
Investigational molecules
Locations
Back to Poland85 clinical trials in Sosnowiec, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
PolandStudy on the Effects of Risankizumab and Adalimumab in Children with Active Juvenile Psoriatic Arthritis
PolandStudy on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis
PolandStudy on the Long-term Safety of Guselkumab for Children with Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis
PolandStudy on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis
PolandA Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis
PolandSafety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne
PolandAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
PolandStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
PolandRandomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis
PolandLong‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma
PolandPhase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on chronic obstructive pulmonary disease (COPD) and asthma management, testing new inhaler formulations and investigating treatments for respiratory conditions including respiratory syncytial virus (RSV).
Studies include evaluation of triple therapy combinations and novel propellant technologies for improved drug delivery.
Research examining treatments for various skin conditions, including atopic dermatitis, psoriasis, and hidradenitis suppurativa, with particular focus on innovative biological therapies.
Clinical investigations include both adult and pediatric populations, testing new targeted therapies.
Studies evaluating treatments for inflammatory bowel conditions, particularly Crohn's disease and ulcerative colitis, testing novel therapeutic approaches for disease management.
Focus on both induction and maintenance therapy for moderate to severe disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.